Cancer drug maker gave last-minute discount deal to HSE

The HSE declined to disclose the price reduction secured

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
12th June, 2016
HSE director general Tony OBrien

The HSE secured a discount on the cancer medicine Pembrolizumab, after the manufacturer offered a last-minute price reduction.

In a letter to health minister Simon Harris, HSE director general Tony O’Brien said pharmaceutical company MSD had offered “revised commercial terms” in May.

In his June 2 letter to Harris, O’Brien confirmed that the HSE directorate had approved funding of the medicine, dubbed ‘Pembro’, which is used to treat advanced melanoma –...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

ESRI predicts health spending will rise due to growing and ageing population

Global tobacco firm lobbies government to keep e-cigarettes free of excise duty

Health Donal MacNamee 2 days ago

Children prescribed adult doses of drugs at Kerry mental health centre

Health Róisín Burke 3 days ago

Patients with rare diseases urge Dáil to pass law on orphan drugs

Health Daniel Murray 5 days ago